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Migraine 
1.1 Migraine without aura 
1.2 Migraine with aura 
1.2.1 Migraine with typical aura 
1.2.2 Migraine with prolonged aura 
1.2.3 Familial hemiplegic migraine 
1.2.4 Basilar migraine 
1.2.5 Migraine aura without headache 
1.2.6 Migraine with acute-onset aura 
1.3 Ophthalmoplegic migraine 
1.4 Retinal migraine 
1.5 Childhood periodic syndromes that may be 
precursors to or associated with migraine 
1.6 Complications of migraine 
1.6.1 Status migrainosus 
1.6.2 Migrainous infarction 
1.7 Migrainous disorder not fulfilling above criteria 
Reprinted with permission from Headache Classification 
Committee of the Intemational Headache Society. ClassiflCatioo 
and diagnostic aiteria for headache disorders, cranial neuralgias 
and facial pain. Cephalalgia. 1988; 8 (suppI7): 13. 
Examples of Reasons to Perfonn 
Neunoimaging Studies in Headache Sufferers 
Neuroimaging may be imported for headache patients 
who have 
• Abnormal unexplained neurological exam 
• Rapidly increasing frequency andlor severity 
headaches 
• Change in headache clinical features 
• First or "worst headache ever experienced 
• Headache with extremely abrupt onset 
• New-onset headache after age 50 
• Headache refractory to aggressive treatment 
• Dizziness, numbness or tingling 
Frishberg B, et al. Evidence-based guidlines in the 
primary care setting : neuroimaging in patients with 
acute headache. Available at: Httpl/:www.aan.com. 
200: Accessed 11114/0 1. 
Evans RW, et al. Neuroimaging and other diagnostic 
testing in headache. In : Silberstein SO, Lipton RB, 
Dalessio DJ, editors. Wolfs Headache and other Pain. 
7th ed. New York, NY: Oxford University Press; 2001. 
p.27-49. 
Figure 3 
Essentially, the major forms of migraine 
are classified according to whether there is 
a preceding aura or not. The diagnosis of 
migraine is a clinical diagnosis, based on 
the history. 
Tension Headache is often misdiagnosed 
as Migraine. 
It is to be noted that Migraine and Tension 
Headache can co-exist in the same patient. 
Care should be taken to distinguish between 
the two. 
Neuroradiological investigations are not 
normally necessary. 
3, Genetic and Environmental 
Factors 
Current evidence from family aggregation 
studies show that if patients suffer from 
migraine with aura, fIrst degree relatives 
have a four-fold increase in risk. 
If the patient has migraine without aura, 
the relative risk for fIrst degree relatives is less. 
However the risk is still appreciably higher 
than that found in a normal population. 
Current evidence would suggest that both 
genetic and environmental causes are 
important in the aetiology of migraine. 
4, Acute treatment 
As both migraine with aura and migraine 
without aura are often self diagnosed, fewer 
patients tend to consult their Family Doctor 
or a Neurologist. Most patients self medicate 
with over the counter products. Around 
60% of patients do well on such a regime 
(fIgure 4). Prescription medications are less 
often used. 
The aims of Acute Treatment should include: 
1. Restoration to normal function as 
soon as possible; 
2. Optimization of self care; 
3. Cost effectiveness; 
4. Minimal or no adverse side effects. 
Drugs which have been shown to be 
effective in well-designed, randornized 
Figure 4 
Patterns of Migraine Medication 
Use in the United States 
Adapted with permission from Lipton RE. et al. Prevalence 
and burden of migraine in the United States: results from 
the American Migrain Study 11. Headache. 2001; 41: 650. 
clinical trials and which have yielded 
consistent satisfactory results include the 
following: Aspirin, Paracetamol, NSAIDS 
and the Triptans. 
Drugs which were shown to be effective 
in at least 1 double-blind controlled trial 
and where there is a clinical impression of 
benefIt, include the anti-emetics 
Metoclopramide and Prochlorperazine. 
The evidence for Ergotamine efficacy is 
conflicting. Ths drug should be avoided 
because of overuse and because of the risks 
of potential severe side effects. 
5. Preventive Treatment 
Individuals who experience frequent and 
disabling attacks may not be adequately 
managed by acute therapy alone. Drug 
prevention therapy will help to reduce the 
frequency, severity and duration of the 
migraine attacks in this group. It could help 
reduce the disability associated with attacks 
and reduce the risk of worsening the migraine 
condition by the overuse of acute 
medications. 
Preventive treatment is to be considered 
in the following situations: 
1. Migraine attacks which recur and 
interfere with daily functioning; 
2, Frequent migraine attacks, 
occurring more than three times 
per month; 
3. When acute medications are not well 
tolerated or ineffective; 
4. When there are contraindications to 
acute medications. 
A number of drugs are used as prophylaxis. 
These include Amitriptyline, Valproate and 
Methysergide. The efficacy of these drugs 
has been shown in multiple well-designed 
randornized clinical trials. 
There is some evidence from clinical trials 
that Gabapentin, Atenolol and Verapramil 
are also effective. 
Topiramate is a recent addition to the 
armamentarium. [3J 
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